InvestorsHub Logo
Followers 91
Posts 4077
Boards Moderated 0
Alias Born 05/24/2011

Re: None

Friday, 01/16/2015 1:01:37 PM

Friday, January 16, 2015 1:01:37 PM

Post# of 402518
Interesting, J&J selling Nucynta opioid pain drug franchise.......maybe they see more value in a new opioid drug franchise, something that is modular and works for all opioids perhaps????


Depomed Inc. on Thursday said it has agreed to pay $1.05 billion to acquire the U.S. rights to Johnson & Johnson's Nucynta opioid pain drug franchise, giving the Newark, N.J.-based company a new flagship product expected to significantly add to revenue and earnings.



http://www.stltoday.com/business/local/depomed-to-pay-b-for-j-j-pain-drug-franchise/article_e4ef3f4d-c84b-57f5-af34-135e58268957.html

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News